• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞上的Fcε受体I将结合IgE的多价抗原递送至MHC II类呈递的组织蛋白酶S依赖性途径。

Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.

作者信息

Maurer D, Fiebiger E, Reininger B, Ebner C, Petzelbauer P, Shi G P, Chapman H A, Stingl G

机构信息

Division of Immunology, Allergy and Infectious Diseases, University of Vienna Medical School, Austria.

出版信息

J Immunol. 1998 Sep 15;161(6):2731-9.

PMID:9743330
Abstract

In this study, we elucidate the Fc epsilon RI-mediated Ag uptake and presentation mechanisms of dendritic cells (DC). We found that Fc epsilon RI-bound IgE, after polyvalent but not after monovalent ligation, is efficiently internalized into acidic, proteolytic compartments, degraded, and delivered into organelles containing MHC class II, HLA-DM, and lysosomal proteins. To follow the fate of the fragmented ligand, we sought to interfere with invariant chain (Ii) degradation, a process critical for peptide loading of nascent MHC class II molecules. We found DC to express cathepsin (Cat) S, a cysteine protease involved in Ii processing by B cells. Exposure of DC to a specific, active-site inhibitor of Cat S resulted in the loss of anti-Cat S immunoreactivity, led to the appearance of an N-terminal Ii remnant, and decreased the export of newly synthesized MHC class II to the DC surface. Furthermore, inactivation of Cat S as well as blockade of protein neosynthesis by cycloheximide strongly reduced IgE/Fc epsilon RI-mediated Ag presentation by DC. Thus, multimeric ligands of Fc epsilon RI, instead of being delivered into a recycling MHC class H pathway, are channeled efficiently into MIIC (MHC class II compartment)-like organelles of DC, in which Cat S-dependent Ii processing and peptide loading of newly synthesized MHC class II molecules occur. This IgE/Fc epsilon RI-dependent signaling pathway in DC may be a particularly effective route for immunization and a promising target for interfering with the early steps of allergen presentation.

摘要

在本研究中,我们阐明了树突状细胞(DC)的FcεRI介导的抗原摄取和呈递机制。我们发现,多价而非单价连接后,与FcεRI结合的IgE能有效地内化到酸性、蛋白水解性区室中,降解并递送至含有MHC II类分子、HLA-DM和溶酶体蛋白的细胞器中。为追踪片段化配体的命运,我们试图干扰恒定链(Ii)的降解,这一过程对新生MHC II类分子的肽负载至关重要。我们发现DC表达组织蛋白酶(Cat)S,这是一种参与B细胞Ii加工的半胱氨酸蛋白酶。将DC暴露于Cat S的特异性活性位点抑制剂会导致抗Cat S免疫反应性丧失,导致N端Ii残余物出现,并减少新合成的MHC II类分子向DC表面的输出。此外,Cat S失活以及用放线菌酮阻断蛋白质生物合成会强烈降低DC的IgE/FcεRI介导的抗原呈递。因此,FcεRI的多聚体配体不是被递送至循环的MHC II类途径,而是有效地被引导至DC的MIIC(MHC II类区室)样细胞器中,在其中发生Cat S依赖性的Ii加工和新合成的MHC II类分子的肽负载。DC中这种IgE/FcεRI依赖性信号通路可能是一种特别有效的免疫途径,也是干扰变应原呈递早期步骤的一个有前景的靶点。

相似文献

1
Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.树突状细胞上的Fcε受体I将结合IgE的多价抗原递送至MHC II类呈递的组织蛋白酶S依赖性途径。
J Immunol. 1998 Sep 15;161(6):2731-9.
2
MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells.MHC II类区室与活化小鼠脾脏树突状细胞中抗原呈递的动力学
J Immunol. 1995 Jun 1;154(11):5715-24.
3
Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation.外周血树突状细胞表达由FcεRIα链和FcεRIγ链组成的复合物形式的FcεRI,并可利用该受体进行IgE介导的过敏原呈递。
J Immunol. 1996 Jul 15;157(2):607-16.
4
MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.B细胞中MHC II类抗原加工:抗原在细胞内的靶向加速
J Immunol. 1999 Jun 15;162(12):7171-80.
5
Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.人B淋巴母细胞在胞吞区室中含有不同模式的组织蛋白酶活性,并以不依赖组织蛋白酶S的方式调节MHC II类分子的转运。
J Leukoc Biol. 2004 May;75(5):844-55. doi: 10.1189/jlb.0803367. Epub 2004 Feb 13.
6
Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments.蛋白激酶C对恒定链的磷酸化作用调节了主要组织相容性复合体II类分子向抗原加工区室的运输。
J Immunol. 1999 Nov 15;163(10):5435-43.
7
Rapid constitutive generation of a specific peptide-MHC class II complex from intact exogenous protein in immature murine dendritic cells.未成熟小鼠树突状细胞中完整外源性蛋白质快速组成性生成特定肽 - 主要组织相容性复合体II类复合物。
Eur J Immunol. 2002 Nov;32(11):3246-55. doi: 10.1002/1521-4141(200211)32:11<3246::AID-IMMU3246>3.0.CO;2-B.
8
MHC class II presentation of endogenously expressed antigens by transfected dendritic cells.转染的树突状细胞对内源性表达抗原的MHC II类呈递
Gene Ther. 2001 Mar;8(6):487-93. doi: 10.1038/sj.gt.3301433.
9
Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane.树突状细胞成熟会触发主要组织相容性复合体II类分子从溶酶体到质膜的逆向转运。
Nature. 2002 Aug 29;418(6901):988-94. doi: 10.1038/nature01006.
10
Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells.不变链加工与原代人 B 细胞/树突状细胞和 B 淋巴细胞母细胞之间的组织蛋白酶变化无关。
Cell Immunol. 2011;269(2):96-103. doi: 10.1016/j.cellimm.2011.03.012. Epub 2011 Mar 17.

引用本文的文献

1
Omalizumab controls surface phenotypes of dendritic cells and monocytes in asthma.奥马珠单抗可控制哮喘中树突状细胞和单核细胞的表面表型。
J Allergy Clin Immunol Glob. 2025 Jun 23;4(3):100523. doi: 10.1016/j.jacig.2025.100523. eCollection 2025 Aug.
2
Omalizumab is ineffective in regulating proasthmatic serum cytokine and chemokine levels in nonresponders with high BMI.奥马珠单抗在调节高体重指数无反应者的促哮喘血清细胞因子和趋化因子水平方面无效。
J Allergy Clin Immunol Glob. 2025 Mar 22;4(2):100462. doi: 10.1016/j.jacig.2025.100462. eCollection 2025 May.
3
Innate Immunity and Asthma Exacerbations: Insights From Human Models.
先天性免疫与哮喘急性发作:来自人体模型的见解
Immunol Rev. 2025 Mar;330(1):e70016. doi: 10.1111/imr.70016.
4
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors.通过靶向树突状细胞受体控制治疗性癌症疫苗中的抗原命运
Mol Pharm. 2023 Oct 2;20(10):4826-4847. doi: 10.1021/acs.molpharmaceut.3c00330. Epub 2023 Sep 18.
5
Transfer learning efficiently maps bone marrow cell types from mouse to human using single-cell RNA sequencing.利用单细胞 RNA 测序,从老鼠到人类高效地转移学习骨髓细胞类型。
Commun Biol. 2020 Dec 4;3(1):736. doi: 10.1038/s42003-020-01463-6.
6
The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab.抗 IgE 治疗性抗体 ligelizumab 的作用机制和功能特征与奥马珠单抗不同。
Nat Commun. 2020 Jan 8;11(1):165. doi: 10.1038/s41467-019-13815-w.
7
Treatment of estrogen-induced dermatitis with omalizumab.用奥马珠单抗治疗雌激素诱导的皮炎。
JAAD Case Rep. 2019 May 25;5(6):481-483. doi: 10.1016/j.jdcr.2019.03.007. eCollection 2019 Jun.
8
Subcutaneous immunotherapy induces alterations in monocytes and dendritic cells homeostasis in allergic rhinitis patients.皮下免疫疗法可诱导变应性鼻炎患者单核细胞和树突状细胞稳态发生改变。
Allergy Asthma Clin Immunol. 2018 Nov 15;14:45. doi: 10.1186/s13223-018-0271-8. eCollection 2018.
9
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.奥马珠单抗,第一种可用于重度哮喘生物治疗的抗体:超过十年的真实世界疗效。
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618810192. doi: 10.1177/1753466618810192.
10
Immunoglobulin E-Mediated Autoimmunity.免疫球蛋白 E 介导的自身免疫
Front Immunol. 2018 Apr 9;9:689. doi: 10.3389/fimmu.2018.00689. eCollection 2018.